FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/02/2022
Back to search
Official data from USPTO
IDSIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IDSIQ
ST13
US500000079308218Class
9, 16, 41, 42
Filing
79308218
Registration
6726798
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
10/02/2022
Trademark type
Word
Nice classes
9, 16, 41, 42
Filing date
12/30/2020
Registration date
05/24/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2022
Last transaction
05/24/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
CH
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Idorsia Pharmaceuticals Ltd
Representatives
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Technical classification
Nice Classes
Class 9Class 16Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable electronic publications in the nature of newsletters and test results in the nature of test results documents and test result forms the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
Class 16
Printed matter in the nature of newsletters and brochures in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
Class 41
Multimedia publication of printed matter in the nature of newslettersbrochurestest results in the nature of test results documents and test result forms in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; multimedia publication of printed matter in the nature of booksmagazines and journals in the field of tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
Class 42
Scientific research and developmentnamely pharmaceutical testing and medical testing services not for diagnostic or treatment purposes and development of pharmaceutical and medical testsall which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; scientific researchnamely analysis of objective data on patients that was acquired by means of diagnostic tests in the context of drug administrationanalysis of subjective data on patients that was acquired by means of patient questioninganalysis of such data with the aim of optimizing drug treatments and drug administration
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/09/2022
FIMP
FINAL DISPOSITION PROCESSED
09/09/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/24/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/24/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/01/2022
PUBO
PUBLISHED FOR OPPOSITION
03/01/2022
GPNX
NOTIFICATION PROCESSED BY IB
02/28/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/09/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/24/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
01/24/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/24/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
01/24/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/24/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/05/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/05/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/05/2022
RFNT
REFUSAL PROCESSED BY IB
08/15/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/26/2021
RFRR
REFUSAL PROCESSED BY MPU
07/26/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/15/2021
CNRT
NON-FINAL ACTION WRITTEN
07/14/2021
DOCK
ASSIGNED TO EXAMINER
07/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
04/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/09/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/08/2021
Continuous trademark protection
Get notified about every new filing that threatens IDSIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.